Previous 10 | Next 10 |
2024-05-05 17:30:00 ET Summary Enovis, the medtech leftover of Colfax, has seen solid growth, but reports highly adjusted earnings and recently has taken on quite some leverage. The company competes in a wide range of activities in the orthopedic market, facing competition from la...
Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry PR Newswire WOBURN, Mass. , May 3, 2024 /PRNewswire/ -- Curiox Bi...
2024-04-30 05:00:55 ET One of the best ways to grab a dividend payer set to surge is a strategy you never hear about anymore: Pick up shares of a conglomerate . I know, I know. The word brings to mind “old school” companies like 3M (MMM) —which we discusse...
2024-04-29 14:39:20 ET Summary Fortive Corporation is a well-positioned conglomerate with high-quality, high-growth businesses in intelligent operating solutions, precision technologies, and advanced healthcare solutions. The company has seen solid growth, and has ambitious midter...
2024-04-27 12:08:00 ET Summary Danaher Corporation's core sales growth rate is expected to turn positive as 2024 progresses. Margins are expected to improve with easing comparisons, cost-cutting, and operating leverage as sales recover. Valuation is reasonable on FY25 and FY26...
2024-04-25 17:01:08 ET Summary Danaher Corporation stock has surged by 16% since our "Strong Buy" rating in June 2023, outperforming the S&P 500. The bioprocessing industry is facing near-term challenges, but long-term growth prospects remain strong. Danaher's Q1 FY24 resu...
2024-04-25 03:21:44 ET Summary Danaher Corporation, a healthcare/biotech/life sciences supplier, has shown resilience and strength in its core businesses despite post-pandemic growth challenges. The company maintains strong margins, consistently generates elevated free cash flow, ...
Danaher Corporation (NYSE: DHR) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 7.2% on the day to $253.08. Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial product...
2024-04-23 10:39:08 ET Danaher Corporation (DHR) Q1 2024 Earnings Conference Call April 23, 2024 08:00 AM ET Company Participants John Bedford - VP of IR Rainer Blair - President & CEO Matthew McGrew - EVP & CFO Conference Call Participants Ja...
2024-04-23 07:01:46 ET The company's financial performance has been impacted by market fluctuations and technological innovations, with revenue growth varying unpredictably. Management is focused on developing new products and services while monitoring industry changes and AI uncertainties. K...
News, Short Squeeze, Breakout and More Instantly...
Danaher Schedules Second Quarter 2024 Earnings Conference Call PR Newswire WASHINGTON , June 24, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2024 on Tuesd...
Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics PR Newswire WASHINGTON , June 19, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), a leading global life sciences and diagnostics innovator, tod...
2024-06-18 19:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...